ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study.

Deborah M Stephens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.